Osteoarthritis Management in Developing Countries

Osteoarthritis (OA) is a prevalent and debilitating musculoskeletal condition affecting millions of individuals worldwide. While it is a global health concern, the impact of OA is particularly profound in developing countries due to resource constraints, limited healthcare infrastructure, and socioeconomic disparities. This chapter provides an overview of the prevalence, morbidity, and mortality of OA in developing countries, highlighting the clinical, economical, and humanistic burdens, as well as the associated costs. It also discusses the causes and risk factors of OA in these regions, its complications, clinical presentation, and diagnosis. The prevalence of OA in developing countries is on the rise, largely driven by aging populations, increasing obesity rates, and changing lifestyles. This surge places an immense burden on healthcare systems, straining already limited resources. OA leads to substantial morbidity, with chronic pain, reduced mobility, and functional impairment significantly impacting the quality of life for affected individuals. The economic burden is equally concerning, encompassing direct medical costs, such as medication and surgical interventions, and indirect costs related to lost productivity. Several risk factors contribute to the development and progression of OA in developing countries, including genetics, obesity, occupational hazards, and inadequate access to healthcare. These risk factors often intersect with challenges related to poverty and inadequate education, exacerbating the burden of the disease. Complications of OA, such as joint deformities and disability, further compound the suffering of individuals. Timely diagnosis is crucial, but it remains a challenge in many developing countries due to limited access to healthcare facilities and diagnostic tools. This chapter underscores the urgent need for comprehensive strategies to address the growing crisis of OA in developing countries. It advocates for the development of guidelines, resources, and educational materials, as well as increased access to healthcare services. Furthermore, it emphasizes the importance of nonpharmacological therapies, patient education, and multidisciplinary care approaches to alleviate the physical, emotional, and economic burdens associated with OA. By implementing these recommendations, developing countries can work toward improving the management and prevention of OA, enhancing the well-being of their populations, and mitigating the societal and economic costs of this debilitating condition.